Prosecution Insights
Last updated: October 04, 2026

Sino Medical Sciences Technology Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Sino Medical Sciences Technology Inc. currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This active matter is assigned to 1 distinct examiner working within 1 distinct art unit. The concentration of the portfolio suggests a specific focus for the company's current prosecution efforts at the patent office. Practitioners should note that the prosecution strategy is currently centralized, which limits the diversity of examiner perspectives encountered by the applicant during this phase.

The busiest examiner for this portfolio is LYNCH, ROBERT A, who is responsible for 1 pending office action. Because the busiest examiner pending count of 1 matches the total volume of active matters, this individual handles the total workload. This creates a situation where the company's immediate patent prospects in the Medical Devices & Mechanical Engineering sector are subject to the specific interpretations of a single official. The lack of multiple distinct art units or examiners means there is no internal baseline for comparing examiner behavior within the current portfolio. Consequently, the applicant must tailor their responses specifically to the known tendencies of the 1 distinct examiner involved to advance their filing toward allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LYNCH, ROBERT A 1 80.3% +12.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18259979 DRUG ELUTING STENT LYNCH, ROBERT A 71d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18259979 DRUG ELUTING STENT LYNCH, ROBERT A 71d overdue

Top Art Units

Art UnitApps
3771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18259979 DRUG ELUTING STENT LYNCH, ROBERT A 3771 §102§112 Non-Final OA 71d overdue Pending Jun 29, 2023

Managing Sino Medical Sciences Technology Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month